Robert Venes

The Illinois and Connecticut-based alternative investment firm has appointed Peter Cannon, a former senior fund manager at Merrill Lynch, to head up its London operations.

Publicly listed London Merchant Securities is to de-merge its venture capital arm, which will be renamed Leo Capital.

Amsterdam-based Life Sciences Partners has launched a new life sciences fund with $100 million from Swiss agribusiness Syngenta. The vehicle will be managed from the firm’s new Boston office, which opens next week.

Jan Amethier, a 12-year veteran of JP Morgan, will join the European mid-market investor this July to focus on the firm’s investments in the Nordic region.

French media group Canal Plus has sold a 60 percent stake in struggling football club Paris St Germain to Butler Capital Partners, Colony Capital and Morgan Stanley.

The US and UK alternative asset management firm has raised over €1bn for its second mezzanine fund focusing on transactions in Europe.

Goldman Sachs Capital Partners led the financial sponsors’ global rankings for banking fee revenue in the first quarter of this year, accounting for 5.2 percent of market share.

The UK mid-market investor has garnered twice the capital raised for its second vehicle, which closed in 2002.

Promethean Investments, the AIM-listed investment vehicle of Sir Peter Burt, has approached London Scottish Bank regarding a 115 pence per share cash offer.

Ian Nolan, a managing director in 3i’s European buyouts arm, will take over responsibilities for the UK buyout operations of the London-listed investor.